Helder Novais Bastos
Overview
Explore the profile of Helder Novais Bastos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magalhaes Ferreira P, Ferreira J, Freitas C, Sousa C, Araujo D, Novais Bastos H, et al.
Monaldi Arch Chest Dis
. 2025 Feb;
PMID: 39992305
Venous thromboembolism (VTE) is highly prevalent in cancer patients. While its actual incidence remains disparate among studies, specific subpopulations, such as lung cancer patients, might be at an increased risk....
2.
Magalhaes Ferreira P, Machado F, Coelho D, Alexandre A, Novais Bastos H, Mota P, et al.
Respir Med
. 2025 Jan;
237:107925.
PMID: 39746490
Introduction And Objectives: International guidelines for the diagnosis of Hypersensitivity Pneumonitis (HP) have improved the diagnostic standardization of this heterogeneous interstitial lung disease. Our goal was to determine how the...
3.
Cardoso C, Valente C, Serino M, Rodrigues I, Carvalho A, Coelho D, et al.
J Bras Pneumol
. 2024 Dec;
50(5):e20240058.
PMID: 39661832
Objective: The frequency of obstructive sleep apnea (OSA) in patients with idiopathic pulmonary fibrosis (IPF) is high. The clinical course of non-IPF interstitial lung disease (ILD) can be similar to...
4.
Araujo M, Beltrao M, Sokhatska O, Melo N, Mota P, Novais Bastos H, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39655167
Introduction: Progressive pulmonary fibrosis (PPF) corresponds to any fibrotic interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF) that presents clinical, physiological and/or radiological evidence of disease progression similar...
5.
Rozman A, Grabczak E, George V, Malovrh M, Novais Bastos H, Trojnar A, et al.
Breathe (Sheff)
. 2024 Aug;
20(2):230201.
PMID: 39193456
Interventional bronchoscopy has seen significant advancements in recent decades, particularly in the context of lung cancer. This method has expanded not only diagnostic capabilities but also therapeutic options. In this...
6.
Rodrigues I, Estevao Gomes R, Coutinho L, Rego M, Machado F, Morais A, et al.
Eur Respir Rev
. 2022 Oct;
31(166).
PMID: 36198419
Introduction: Transbronchial lung cryobiopsy (TBLC) is increasingly being used as an alternative to video-assisted thoracoscopic surgery (VATS) biopsy to establish the histopathologic pattern in interstitial lung disease (ILD). Methods: A...
7.
Goncales R, Novais Bastos H, Duarte-Oliveira C, Antunes D, Sokhatska O, Jacob M, et al.
Am J Respir Crit Care Med
. 2022 Jun;
206(9):1140-1152.
PMID: 35767663
Sarcoidosis is a multisystemic inflammatory disease characterized by the formation of granulomas in response to persistent stimuli. The long pentraxin PTX3 (pentraxin 3) has emerged as a component of humoral...
8.
Coelho D, Boaventura R, Meira L, Guimaraes S, Moura C, Mota P, et al.
Respiration
. 2021 Nov;
101(1):67-75.
PMID: 34818255
Background: Pneumothorax is one of the main complications of transbronchial lung cryobiopsy (TBLC). Chest ultrasound (CUS) is a radiation-free alternative method for pneumothorax detection. Objective: We tested CUS diagnostic accuracy...
9.
Coelho D, Santos V, Araujo D, Novais Bastos H, Magalhaes A, Hespanhol V, et al.
Front Mol Biosci
. 2021 Aug;
8:639676.
PMID: 34368223
Background: Cancer patients appear to be at a higher risk of complications from coronavirus disease 2019 (COVID-19). Specific data related to lung cancer (LC) patient management, active treatment, and/or recent...
10.
Rocha D, Magalhaes C, Ca B, Ramos A, Carvalho T, Comas I, et al.
Front Microbiol
. 2021 Jun;
12:659545.
PMID: 34177837
Widespread and frequent resistance to the second-line tuberculosis (TB) medicine streptomycin, suggests ongoing transmission of low fitness cost streptomycin resistance mutations. To investigate this hypothesis, we studied a cohort of...